Skip to main content
Signal8

Paradigm Biocapital Advisors LP

Paradigm Biocapital Advisors LP is an Investment Adviser institutional filer with the SEC under CIK 1855655, reporting 28 portfolio positions, with 20 historical 13F filings on file. Most recent reporting period: 2026-06-30.

A Form 13F reports a manager's US-listed stock and option positions only. It does not include real estate, private funds, bonds, cash or non-US holdings, so a 13F portfolio value is not the firm's total assets under management (AUM).

  • State of incorporation: DE
  • Filing type: 13F-HR
  • Latest reporting period: 2026-06-30
  • Last filed: 2026-08-14

Top 10 portfolio positions

The largest reported holdings in Paradigm Biocapital Advisors LP's most recent 13F filing, ranked by reported market value.

  1. REVOLUTION MEDICINES INC (RVMD)
  2. NUVALENT INC (NUVL)
  3. EDGEWISE THERAPEUTICS INC (EWTX)
  4. GENMAB A/S (GMAB)
  5. SPYRE THERAPEUTICS INC (SYRE)
  6. APOGEE THERAPEUTICS INC (APGE)
  7. ORUKA THERAPEUTICS INC (ORKA)
  8. TANGO THERAPEUTICS INC (TNGX)
  9. BELITE BIO INC (BLTE)
  10. ERASCA INC (ERAS)
/